Transaction #5918 · Form 4 · 0000805928-25-000134
Axogen, Inc. · Exercise / conversion · Common Stock
Axogen, Inc. · Transacted November 6, 2025 · Filed November 7, 2025
What does this filing report?
An SEC Form 4 filing for Axogen, Inc. records an exercise / conversion involving Common Stock on November 6, 2025. The reported quantity was 5,347. The filing date is November 7, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Axogen, Inc.
- Company CIK
- 0000805928
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 5,347
- Reported price
- 8.14
- Reference value
- 43,524.58
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 5,447
- Ownership description
- Not reported
- SEC acceptance time
- Nov 7, 2025, 4:52 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Burke William P. Mr. ↗
Director
CIK 0001682069
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2
- The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.06 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3
- This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.